Funding for this research was provided by:
National Institutes of Health (P30EY010572, P30CA069533, S10OD012246)
Achievement Rewards for College Scientists Foundation
Robert W. and Elise Franz
Lynn and Jack Loacker
Wes and Nancy Lematta
M.J. Murdock Charitable Trust
Received: 18 February 2018
Accepted: 27 February 2018
First Online: 5 April 2018
Ethics approval and consent to participate
: Recognized principles of laboratory animal care were followed (Guide for the Care and Use of Laboratory Animals, National Research Council, 2011), and all animal protocols were approved by the EACRI Animal Care and Use Committee. All mice were maintained in a specific pathogen–free environment. No humans were treated in this study and therefore ethical approval per Helsinki Declaration was not required.
: All authors provide their consent for publication of this manuscript.
: BAF is a co-founder of UbiVac, which has licensed the autophagosome-enriched vaccine intellectual property. The other authors declare no potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.